19 episodes

The Cancer SIGNAL brings together experts from the cancer community to discuss the latest innovations transforming cancer detection and shifting the cancer paradigm. The podcast is presented by GRAIL and hosted by Kim Thiboldeaux, former CEO and Executive Chair of the Cancer Support Community.

The Cancer SIGNAL GRAIL

    • Health & Fitness
    • 5.0 • 20 Ratings

The Cancer SIGNAL brings together experts from the cancer community to discuss the latest innovations transforming cancer detection and shifting the cancer paradigm. The podcast is presented by GRAIL and hosted by Kim Thiboldeaux, former CEO and Executive Chair of the Cancer Support Community.

    18 – When a Proactive Cancer Screening Leads to a Surprising Diagnosis

    18 – When a Proactive Cancer Screening Leads to a Surprising Diagnosis

    After supporting her husband through his shocking cancer experience, Cindy decided to take a multi-cancer early detection test as recommended by her doctor. She was once again shocked when she received a “cancer signal detected” result, leading to a cancer diagnosis. Join us to hear about Cindy’s experience with early detection, treatment, and eventual remission, and what she learned along the way.
    We want your feedback! Please take our podcast survey: https://bit.ly/42R4wGi 
    Transcripts: https://grail.com/podcast/ 
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 16 min
    17 – Navigating Hereditary Cancer Risk – Part 2

    17 – Navigating Hereditary Cancer Risk – Part 2

    Join host Kim Thiboldeaux and Krissa Smith, VP of Mission Partnerships at Susan G. Komen, as they continue unraveling how the BRCA gene and other DNA mutations impact hereditary cancer risk. In this episode, Krissa shares personal stories about her family's experiences with genetic testing and how they’ve chosen to respond. Krissa also discusses cancer screening best practices and how multi-cancer early detection testing can play a role.
    Please take our survey to help us shape future episodes: https://bit.ly/3sQkbrN  
    Transcripts: https://grail.com/podcast/
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 15 min
    16 – Understanding BRCA Mutations and Hereditary Cancer Risk – Part 1

    16 – Understanding BRCA Mutations and Hereditary Cancer Risk – Part 1

    Krissa Smith, Vice President of Mission Partnerships at Susan G. Komen, joins us to discuss the complexities of the BRCA gene and its impact on hereditary cancer risk. Krissa shares her family's experiences with genetic mutations, including the p53 gene, and explains the importance of genetic testing and how it can work in partnership with evolving cancer screening technology. Stay tuned for part 2 to learn more about genetics, cancer risk, and the importance of early detection.
    Please take our survey to help us shape future episodes: https://bit.ly/3sQkbrN  
    Transcripts: https://grail.com/podcast/
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 17 min
    15 – Meet Tami: Cancer Survivor Turned Advocate

    15 – Meet Tami: Cancer Survivor Turned Advocate

    Meet Tami, manager of a Christmas tree farm in rural Oregon. Cancer has had a profound impact on Tami’s life, from her grandmother's diagnosis more than 30 years ago to her own 2017 diagnosis to her participation in the PATHFINDER study. Tami shares what she’s learned about cancer and the importance of proactive screening, including her own experiences with multi-cancer early detection (MCED) testing. 
    Please take our survey to help us shape future episodes: https://bit.ly/3sQkbrN 
    Transcripts: https://grail.com/podcast/ 
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 22 min
    14 – The COVID-19 Pandemic’s Impact on Cancer Screenings

    14 – The COVID-19 Pandemic’s Impact on Cancer Screenings

    In the years since the COVID-19 pandemic began, cancer screening has changed, necessitating inventive strategies. Epidemiologists  Dr. Alpa Patel (Senior Vice President of Population Science, American Cancer Society) and Dr. Tina Clarke (Vice President of Epidemiology and Distinguished Scientist, GRAIL) return to The Cancer SIGNAL to discuss how the pandemic changed access to cancer screening, the impact it had on diagnosing cancer, and where that leaves the screening landscape today.  
    Please take our survey to share your thoughts on The Cancer SIGNAL: https://bit.ly/3sQkbrN 
    Transcripts: https://grail.com/podcast/ 
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 30 min
    13 – What did the PATHFINDER Study Reveal about Multi-Cancer Early Detection Testing?

    13 – What did the PATHFINDER Study Reveal about Multi-Cancer Early Detection Testing?

    What did researchers learn when they studied a multi-cancer early detection test in a population of more than 6,000 patients? The PATHFINDER study, recently published in The Lancet, explored that question and produced useful insights. Dr. Chuck McDonnell, a radiologist with Sutter Medical Group and principal investigator for PATHFINDER, joins this episode to discuss how the study worked, highlights of the results, and what they could mean for the future of cancer screening. 
    Transcripts available at https://grail.com/podcast/ 
    Sign up for GRAIL’s newsletter: https://grail.com/newsletter-signup/

    • 17 min

Customer Reviews

5.0 out of 5
20 Ratings

20 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
iHeartPodcasts
Peter Attia, MD
Ten Percent Happier
Ramsey Network
John R. Miles

You Might Also Like

Peter Attia, MD
Jason Bateman, Sean Hayes, Will Arnett
This American Life
NPR
audiochuck
NBC News